A Multiplex Implantable Microdevice Assay Identifies Synergistic Combinations of Cancer Immunotherapies and Conventional Drugs

Researchers integrated high-throughput and high-content techniques to investigate the tumor cell and immunological response signatures to different treatment regimens.